Abstract This review focuses on the mechanisms of action of histone deacetylase (HDAC) inhibitors (HDACi), a group of recently discovered targeted anticancer agents
He answered all of my questions
Based on VigiBase, the World Health Organizations (WHO) adverse drug reaction database, intestinal obstructions are reported over 4.5 times more frequently with incretin-based drugs than with other diabetes medications [10]
Kristi Perry, PA-C Eli Luft, PA-C Key Takeaways 1
In clinical trials, 6-16% of participants discontinued retatrutide due to gastrointestinal adverse events (Jastreboff et al., NEJM, 2023)
Advanced molecular imaging and profiling methods are essential tools in this effort, and studies linking VEGF expression to BBB dysfunction and neurodegenerative pathology provide important insights (Dohgu and Banks 2013)